Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Cl2a-sn-38 | 1279680-68-0 | 1480.61 | C73H97N11O22 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY12894650MG

Encompass_Preferred

CL2A-SN-38 is a drug-linker conjugate composed of the DNA topoisomerase I inhibitor SN-38 linked via a hydrolyzable CL2A linker, intended for antibody-drug conjugate (ADC) research and development. It releases active SN-38 within tumor cells and the tumor microenvironment, producing bystander antitumor effects.

  • Drug-linker conjugate designed for ADC development.
  • Releases SN-38 within tumor cells and tumor microenvironment.
  • Camptothecin-class topoisomerase I inhibitor mechanism.
  • Molecular formula C73H97N11O22; molecular weight 1480.61.
  • Soluble in DMSO (100 mg/mL) and in documented in vivo formulations.
  • Store at -20°C under nitrogen; in solution -80°C (6 months) or -20°C (1 month).

Catalog No. 50-002-02294


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.